https://pharma.economictimes.indiatimes.com/news/pharma-industry/atai-and-recognifys-schizophrenia-drug-fails-trial-shares-plummet-17/122917974
Atai Life Sciences: Atai and Recognify's Schizophrenia Drug Fails Trial, Shares Plummet 17%,...
Atai Life Sciences and Recognify Life Sciences announced that their schizophrenia-linked cognitive impairment drug, inidascamine, failed to meet key trial...
https://www.recognify.org/
Recognify, Recognize, Clarify, Grow
Recognify is a science-based self-leadership app that helps you build self-awareness, break old patterns, and grow with personalised psychology and behavioural...
recognizeclarifygrow